← Leaderboards
Robert M Straubinger
State University Of New York At Buffalo
$4,875,752
Attributed
$7,377,707
Total exposure
15
Grants
8
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $987.7K · FY2005–20$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
Funding mix
By agency
NIH$7,696,445 · 16
By mechanism
R01$3,929,202 · 3
S10$2,341,733 · 10
R21$1,425,510 · 3
Top collaborators
- Wen Wee Ma7 shared
- Chris Scott5 shared
- Jun Qu4 shared
- Niall Barron3 shared
- Martin Clynes2 shared
- Donald E Mager2 shared
- Alexis Cassandra Thompson2 shared
Most similar at State University Of New York At Buffalo
Same institution · by research overlap
- Ronald Berezney$2,863,723
- Wen Wee Ma$737,204
- Chris Scott$539,205
- Jun Qu$2,101,366
- Niall Barron$327,737
Others in their field
Top investigators on “Pharmaceutical Preparations”
- Sonia M Thomas · Research Triangle Institute$701,865,642
- Tracy L Nolen · Research Triangle Institute$474,487,152
- David Heimbrook · Leidos Biomedical Research, Inc.$266,816,120
- Leonard Freedman · Leidos Biomedical Research, Inc.$240,520,687
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$196,976,947
- Lawrence Corey · Fred Hutchinson Cancer Center$196,976,947
Research focus
Pharmaceutical PreparationsBaseCharacteristicsDesignMalignant NeoplasmsDiagnosisNeoplastic CellPharmacologyTumorPharmacodynamicsPaclitaxelInvestigationPenetrationPerfusionDrug CarriersComplexDrug Delivery SystemsMalignant Neoplasm Of PancreasBlood VesselsMediatingBloodCancer CellDepositionPermeability
Grant awards (29)
Large-scale proteome-wide analysis with high accuracy/precision to guide pancreatic cancer therapy development$180,399
R21 · FY2020 · CA · contact PI
Tumor priming sequences combined with novel nanoparticle drug carriers for enhanced therapeutic efficacy in pancreatic cancer: a tripartite USA/Northern Ireland/Republic of Ireland consortium$416,494
R01 · FY2019 · CA · contact PI
Large-scale proteome-wide analysis with high accuracy/precision to guide pancreatic cancer therapy development$218,284
R21 · FY2019 · CA · contact PI
Tumor priming sequences combined with novel nanoparticle drug carriers for enhanced therapeutic efficacy in pancreatic cancer: a tripartite USA/Northern Ireland/Republic of Ireland consortium$429,377
R01 · FY2018 · CA · contact PI
Tumor priming sequences combined with novel nanoparticle drug carriers for enhanced therapeutic efficacy in pancreatic cancer: a tripartite USA/Northern Ireland/Republic of Ireland consortium$429,377
R01 · FY2017 · CA · contact PI
Tumor priming sequences combined with novel nanoparticle drug carriers for enhanced therapeutic efficacy in pancreatic cancer: a tripartite USA/Northern Ireland/Republic of Ireland consortium$429,377
R01 · FY2016 · CA · contact PI
Tumor priming sequences combined with novel nanoparticle drug carriers for enhanced therapeutic efficacy in pancreatic cancer: a tripartite USA/Northern Ireland/Republic of Ireland consortium$452,195
R01 · FY2015 · CA · contact PI
Pancreas cancer combination therapy based on stromal modulators and nano-carriers$167,489
R21 · FY2013 · CA · contact PI
Pancreas cancer combination therapy based on stromal modulators and nano-carriers$228,508
R21 · FY2012 · CA · contact PI
Peripheral biomarkers of cocaine dependence and relapse$313,830
R21 · FY2010 · DA · contact PI
Circular Dichroism Spectropolarimeter with fluorescence acquisition and temperatu$131,824
S10 · FY2010 · RR · contact PI
Peripheral biomarkers of cocaine dependence and relapse$317,000
R21 · FY2009 · DA · contact PI
High Performance Computational System to Support LCMS/Proteomics Analysis$238,157
S10 · FY2009 · RR · contact PI
Drug carrier of blood/tumor/brain permeability$290,879
R01 · FY2008 · CA · contact PI
High sensitivity liquid chromatography tandem mass spectrometry system$500,000
S10 · FY2007 · RR · contact PI
Drug carrier of blood/tumor/brain permeability$290,879
R01 · FY2007 · CA · contact PI
Drug carrier of blood/tumor/brain permeability$299,566
R01 · FY2006 · CA · contact PI
Drug carrier of blood/tumor/brain permeability$49,952
R01 · FY2006 · CA · contact PI
LC/quadrupole ion trap mass spectroscopy system$318,738
S10 · FY2005 · RR
Drug carrier of blood/tumor/brain permeability$309,340
R01 · FY2005 · CA
LC/QUADRUPOLE ION TRAP MASS SPECTROSCOPY SYSTEM: PHARAMACEUTICAL SCIENCES$143,432
S10 · FY2005 · RR
LC/QUADRUPOLE ION TRAP MASS SPECTROSCOPY SYSTEM: PROTEOMICS$127,495
S10 · FY2005 · RR
LC/QUADRUPOLE ION TRAP MASS SPECTROSCOPY SYSTEM: AIDS$47,811
S10 · FY2005 · RR
Drug carrier of blood/tumor/brain permeability$40,857
R01 · FY2005 · CA
Drug carrier of blood/tumor/brain permeability$315,235
R01 · FY2004 · CA
Stopped flow spectrofluorometer$218,486
S10 · FY2002 · RR
CHEMICAL, BIOLOGICAL AND DRUG DISCOVERY COMPUTING SYSTEM$195,860
S10 · FY2001 · RR
LIQUID CHROMATOGRAPHY/MASS SPECTROSCOPY SYSTEM$419,930
S10 · FY2000 · RR
TAXOL--MICROTUBULE PHYSICAL INTERACTIONS$175,674
R01 · FY2000 · CA